Announcements Trials
Browse Landscape

Phase

Phase NA 24Phase 4 4Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 61Terminated 15Withdrawn 10Recruiting 10Unknown 7Active not recruiting 4Not yet recruiting 2Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 419Thoracic 249Breast 171Genitourinary 106Lymphoid 101Gynecologic 98Head & Neck 93Other hematologic neoplasm 74CNS 57Sarcoma 29Other solid neoplasm 27Dermatologic 26Tumor-Agnostic 25Plasma cell 24Myeloid 15Endocrine 12Classical hematology 12NET 3Other neoplasm 2Other 2

Conditions

Obesity 2Overweight 1Hyperplasia 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Other × Clear all
NCT07078838 2026-01-16

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

NCT07314528 2026-01-02

Evaluating the Impact of GLP-1 Receptor Agonists With Total Neoadjuvant Therapy in Rectal Cancer

St. James's Hospital, Ireland

Phase 2 Not yet recruiting
42 enrolled
Other

Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡